Patients and doctors report difficulty accessing certain estrogen patches, but the FDA has not yet added the medication to its official drug shortage list.
Patients and medical professionals report challenges in obtaining specific estrogen patches, though the FDA has not officially designated the medication as being in shortage.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
Open map near United States
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
Briefings
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.